About Us
Timeline of Major Milestones
|
Year / Date |
Milestone |
|
2022/5/5 |
ECM Biomedical Co., Ltd. was established with a paid-in capital of NT$20.25 million. |
|
2022/12/30 |
Completed construction of a Class 10,000 cleanroom and passed environmental validation. |
|
2023/2/28 |
Signed a collaboration agreement with a U.S. non-profit tissue procurement organization. |
|
2023/3/8 |
Passed TFDA document review and obtained trial operation approval for the Amniotic Membrane Human Organ Preservation Bank. |
|
2023/3/14 |
Completed the first capital increase, raising paid-in capital to NT$40.5 million. |
|
2023/11/27 |
Passed TFDA review and obtained establishment approval for the Amniotic Membrane Human Organ Preservation Bank. |
|
2024/4/16 |
Acquired trademarks for AmnioLink® and AmnioForm amniotic membrane products. |
|
2024/7/26 |
Completed the second capital increase, raising paid-in capital to NT$60 million. |
|
2024/12/16 |
Passed TFDA document review and obtained trial operation approval for additional tissue categories, including skin, cortical bone, cartilage, fascia, ligament, and bone powder. |
|
2025/3/25 |
Completed the third capital increase, raising paid-in capital to NT$90 million. |
|
2025/5/9 |
TFDA conducted on-site inspection for the new categories under the Human Organ Preservation Bank, including skin, cortical bone, cartilage, fascia, ligament, and bone powder. |
|
2025/6/1 |
Joined the TMU BioMed Accelerator. |
|
2025/7/1 |
Completed implementation of the ERP system. |
|
2025/8/31 |
Passed TFDA review and obtained establishment approval for the Human Organ Preservation Bank – Cortical Bone, Bone Powder, and Skin. |
